NYSE:MRX Medicis Pharmaceutical (MRX) Stock Price, News & Analysis → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free MRX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$19.00▼$19.5750-Day Range N/A52-Week Range N/AVolume127,777 shsAverage Volume840,093 shsMarket Capitalization$1.35 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisHeadlinesOptions ChainSocial MediaStock AnalysisHeadlinesOptions ChainSocial Media Get Medicis Pharmaceutical alerts: Email Address Ad Crypto 101 Media[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. About Medicis Pharmaceutical Stock (NYSE:MRX)Medicis Pharmaceutical Corporation (Medicis) together with its wholly owned subsidiaries is an independent specialty pharmaceutical company engaged in the development and marketing of products for the treatment of dermatological and aesthetic conditions in the United States and Canada. Medicis offers a range of products addressing various conditions or aesthetic improvements, including facial wrinkles. Its brands are DYSPORT (abobotulinumtoxinA) 300 Units for Injection, PERLANE Injectable Gel, RESTYLANE Injectable Gel, SOLODYN (minocycline HCl, USP) Extended Release Tablets, VANOS (fluocinonide) Cream 0.1%, ZIANA (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel and ZYCLARA (imiquimod) Cream 3.75% and 2.5%. As of December 31, 2011, it offered 27 branded products. On December 2, 2011, it acquired Graceway Pharmaceuticals, LLC (Graceway). On November 1, 2011, Medicis sold Medicis Technologies Corporation, formerly LipoSonix, Inc., to Solta Medical, Inc. (Solta).Read More Ad Crypto 101 Media[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. MRX Stock News HeadlinesMay 16 at 7:10 AM | globenewswire.comMarex Group plc Announces Full Year 2023 Results and Q1 2024 UpdateMay 15, 2024 | bbc.co.ukThe MediciMay 13, 2024 | globenewswire.comMarex Group plc to Report FY 2023 Results and Q1 2024 Update on May 16, 2024May 10, 2024 | morningstar.comMister Spex SE MRXApril 29, 2024 | investorplace.comWhy Is Marex (MRX) Stock On the Move Today?April 25, 2024 | finance.yahoo.comIPOs Shine Bright in a Tough Day for StocksApril 24, 2024 | reuters.comBritish commodities platform Marex prices US IPO at $1.35 bln valuationApril 24, 2024 | globenewswire.comMarex Group plc Announces Pricing of Initial Public OfferingApril 15, 2024 | globenewswire.comMarex Group plc Announces Launch of Initial Public OfferingDecember 20, 2023 | seekingalpha.comTLPPF Telix Pharmaceuticals LimitedDecember 5, 2023 | finance.yahoo.comPrime Therapeutics announces Ken Bodmer as chief financial officerNovember 1, 2023 | morningstar.comAcelRx Pharmaceuticals Inc ACRXOctober 5, 2023 | finance.yahoo.comPRIME THERAPEUTICS/MAGELLAN RX EXPANDS PARTNERSHIP WITH MHK TO MANAGE MEMBER ENROLLMENT WITH MARKETPROMINENCE TECHNOLOGYMarch 27, 2023 | uk.finance.yahoo.comAnanda Developments Plc - Result of General MeetingMarch 23, 2023 | bizjournals.comBoston Pharmaceuticals NewsMarch 9, 2023 | finanznachrichten.deAnanda Developments Plc - Acquisition of MRX and SubscriptionSeptember 20, 2022 | markets.businessinsider.comXpira Pharmaceuticals Inc. Receives FDA Approval For Psilocybin Trial IND ApplicationAugust 31, 2022 | thestreet.comMedicis to Acquire InamedJanuary 22, 2022 | thestreet.comMedicis Stock Hits New 52-Week High (MRX)January 5, 2022 | investing.comMedicis Pharmaceutical Corp (MRX)See More Headlines Receive MRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medicis Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/19/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorFinance Industry N/A Sub-IndustryN/A Current SymbolNYSE:MRX CUSIPN/A CIK859368 Webwww.Medicis.com Phone+1-212-5992000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares70,820,000Free Float68,134,000Market Cap$1.35 billion OptionableOptionable BetaN/A Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesRobert Roswell Chai-Onn (Age 44)Executive Vice President, General Counsel, Secretary, Director Howard Bradley Schiller (Age 53)Officer, Director Ryan WeldonOfficer, DirectorKey CompetitorsAmerican Assets TrustNYSE:AATFinVolution GroupNYSE:FINVPathward FinancialNASDAQ:CASHJBG SMITH PropertiesNYSE:JBGSElme CommunitiesNYSE:ELMEView All Competitors MRX Stock Analysis - Frequently Asked Questions When did Medicis Pharmaceutical IPO? Medicis Pharmaceutical (MRX) raised $292 million in an initial public offering on Thursday, April 25th 2024. The company issued 15,384,615 shares at $19.00 per share. When does the company's quiet period expire? Medicis Pharmaceutical's quiet period expires on Tuesday, June 4th. Medicis Pharmaceutical had issued 15,384,615 shares in its initial public offering on April 25th. The total size of the offering was $292,307,685 based on an initial share price of $19.00. During the company's quiet period, insiders and any underwriters involved in the IPO are restricted from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company. This page (NYSE:MRX) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBuy this small stock before coming AI Tidal WaveChaikin AnalyticsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicis Pharmaceutical Corp Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.